London Landmarks Half Marathon
📅 Sunday 4 April 2027
📍 London
👟 13.1 Miles
About the event
Join Team Target for the LLHM 2027, the only half marathon to go through both the City of London and City of Westminster.
I need a charity place
Join the team for the London Landmarks Half.
Registration fee:
Sponsorship target:
I have my own place
Already secured a place in the event? Use it to raise money for Target Ovarian Cancer.
Registration fee: Free
The support you'll receive
Support from a member of the fundraising team, to help you every step of the way.
Fundraising advice and top tips to increase your sponsorship.
Free fundraising materials to help you raise awareness of your challenge and the charity.
A Target Ovarian Cancer running top.
Access to useful training and nutritional tips.
Your impact
The money you raise helps us continue to help everyone affected by ovarian cancer.
From frontline support and GP education, to securing national policy change on cervical screening information and delivering national awareness campaigns, our work is targeting life-saving early diagnosis and support.
By joining Team Target, you're bringing us a step closer to a future where life isn’t limited by ovarian cancer.
Lisa ran the LLHM 2026 dressed as ovaries in memory of her mum, Patricia.
“In January 2024 my mum, passed away from ovarian cancer. I wanted to do something fun in memory of mum, whilst also raising awareness of the easily missed symptoms of ovarian cancer. That’s how I found Target Ovarian Cancer and the rest as they say is history.
"Going into 2026, my original idea had been to do two half marathons – one for mum and one for dad. I also turn 50 this year so thought that after that I would hang up my running shoes and enjoy some rest. However, it’s snowballed slightly with a Guinness World Record... and a new name ‘Wonder Wombman’ so who knows where this challenge will lead." - Lisa
Lisa raised over £4000 and is now a Guiness World Record holder. Shortly after event day, she had her ovaries removed as a preventative step to eliminate her genetic risk of ovarian cancer.
